U.S. Markets close in 42 mins.

Aralez Pharmaceuticals Inc. (ARZ.TO)


Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
1.79+0.05 (+2.87%)
As of 1:13PM EDT. Market open.
Full screen
Previous Close1.74
Open1.76
Bid1.77 x
Ask1.79 x
Day's Range1.76 - 1.80
52 Week Range1.46 - 8.75
Volume36,484
Avg. Volume54,526
Market Cap117.86M
Beta0.80
PE Ratio (TTM)-1.21
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend Date2013-12-31
1y Target EstN/A
  • Zacks Small Cap Researchlast month

    ARLZ: Zontivity to be Officially Launched in June 2017

    On May 8, 2017, Aralez Pharmaceuticals Inc. (ARLZ) announced financial results for the first quarter of 2017 and provided a business update. The $26.0 million of revenue consisted of $6.7 million in net product revenues, which are derived from the product portfolio acquired from the acquisition of Tribute along with net product revenues from YOSPRALA® and Fibricor®. Other revenues of $19.3 million were comprised of $15.6 million in revenues from the acquisitions of Toprol-XL® and Zontivity® and Vimovo® royalties of $3.7 million.

  • Associated Presslast month

    Aralez Pharmaceuticals reports 1Q loss

    On a per-share basis, the Milton, Ontario-based company said it had a loss of 42 cents. The specialty pharmaceutical company posted revenue of $26 million in the period. Aralez Pharmaceuticals expects ...

  • Why Aralez Pharmaceuticals Inc. Got Slaughtered Today
    Motley Fool3 months ago

    Why Aralez Pharmaceuticals Inc. Got Slaughtered Today

    Fourth-quarter earnings and guidance for 2017 were not what the doctor ordered.